ストックスクリーナーアプリを入手
2.61
3.57%
0.09
前日終値:
$2.52
開ける：
$2.44
24時間の取引高:
92,169
Relative Volume:
1.02
時価総額：
$6.31M
収益：
$5.31M
当期純損益:
$-2.90M
株価収益率:
-1.757
EPS:
-1.4855
ネットキャッシュフロー:
$-1.18M
1週間 パフォーマンス:
+23.70%
1か月 パフォーマンス:
+24.88%
6か月 パフォーマンス:
-36.80%
1年 パフォーマンス:
-10.92%
1日の値動き範囲:
$2.3513
$2.61
1週間の範囲:
$1.85
$2.70
52週間の値動き範囲:
$1.07
$15.60
Bionexus Gene Lab Corp Stock (BGLC) Company Profile
名前
Bionexus Gene Lab Corp
電話
1-307-241-6898
住所
10-2 TOWER B, VERTICAL BUSINESS SUITE,, KUALA LUMPUR
Compare BGLC vs MOBBW, SHMD, GOODO, PSNYW, DWLD
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
BGLC
BioNexus Gene Lab Corp Common stock
|
0.343 | 201.51M | 0 | 0 | 0 | 0.00 |
MOBBW
Mobilicom Limited Warrants
|
2.38 | 3.16B | 0 | 0 | 0 | 0.00 |
SHMD
Schmid Group N V
|
6.54 | 425.01M | 52.15M | -21.46M | 0 | -0.4675 |
GOODO
Gladstone Commercial Corporation
|
20.26 | 372.90M | 0 | 0 | 0 | 0.00 |
PSNYW
Polestar Automotive Holding Uk
|
2.909 | 269.09M | 2.07B | -1.42B | -1.37B | -0.6765 |
DWLD
Davis Select Worldwide ETF
|
46.61 | 0 | 0 | 0 | 0 | 0.00 |
Bionexus Gene Lab Corp (BGLC) 最新ニュース
BioNexus Gene Lab Corp (BGLC) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
BioNexus Gene Lab Corp (BGLC) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
BioNexus Gene Lab Corp (BGLC) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
BioNexus Gene Lab Corp (BGLC) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
BioNexus Gene Lab Corp (BGLC) Institutional Confidence - TradingKey
BioNexus Gene Lab Corp (BGLC) Valuation: PE, PB & Fair Value Analysis - TradingKey
BioNexus Gene Lab Corp (BGLC) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
BioNexus Gene Lab Corp (BGLC) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
BioNexus Gene Lab Corp (BGLC) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
BioNexus Gene Lab Corp (BGLC) Edges Higher as Shares Hold Above Key Support at $2.47Channel Breakout - newsline.com
12 Industrials Stocks Moving In Thursday's Pre-Market Session - Benzinga
BioNexus Gene Lab Corp (BGLC) Slips 4.1%: Testing Key Support at $2.09Elliott Wave Entry - newsline.com
BioNexus Gene Lab Calls for Malaysia–China Biotech Co-Development and Precision Healthcare Collaboration 1 - Minichart
BioNexus Gene Lab Urges Malaysia–China Co-Development of Biotech Platforms After Kuala Lumpur Forum - TradingView
BioNexus Gene Lab (Nasdaq: BGLC) pushes Malaysia–China biotech co-development model - Stock Titan
BioNexus Gene Lab Corp (BGLC) Declines 8.33% as Stock Approaches Key SupportHigh Beta Stocks - The Legal Advocate
BioNexus Gene Lab Corp (BGLC) Slides 4.17% as Support Level Nears – Key Levels to WatchRating Change - newsline.com
BioNexus Gene Lab Corp (BGLC) Slides 6.25%: Key Support Zone Under ScrutinyCash Flow Strong Stocks - The Legal Advocate
BioNexus Gene Lab Corp. Calls for Malaysia-China Biotechnology Collaboration Focused on Joint Development - geneonline.com
BioNexus Gene Lab Corp. Calls for Malaysia–China - GlobeNewswire
Turning Malaysia into a bridge for China’s biotech ambitions - Stock Titan
BioNexus Gene Lab Stock Edges Up While Nasdaq Microcap Faces Chemrex Cash Battle - Bez Kabli
12 Industrials Stocks Moving In Wednesday's After-Market Session - Sahm
BioNexus Gene Lab Corp (BGLC) Surges 8.44%: Testing Key Resistance at $2.30Channel Breakout - The Legal Advocate
BioNexus Gene Lab (BGLC) Extends Decline, Tests Key Support at $1.92Crowd Entry Signals - Newser
BioNexus Gene Lab Corp 1Q 2026: Revenue $22.84K, EPS ($0.23) — 10-Q Summary - TradingView
BioNexus Gene Lab Corp. Reports Earnings Results for the First Quarter Ended March 31, 2026 - marketscreener.com
[10-Q] BioNexus Gene Lab Corp Quarterly Earnings Report - Stock Titan
BGLC | BioNexus Gene Lab Corp Insider Trading - Quiver Quantitative
TradingKey - TradingKey
Is BioNexus Lab (BGLC) stock fading in strength |Community Buy Alerts - newser.com
BioNexus Lab (BGLC) Risk Reward Ratio | BioNexus Gene Lab posts strong revenue, net lossCertified Trade Ideas - Xã Vĩnh Công
BioNexus Gene Lab: Chemical Raw Materials & Genomic Screening Business Overview, Growth Strategies, and Market Insights 19233034 - Minichart
BioNexus Gene Lab 10-K: Revenue $7.42M, EPS $(1.61) - TradingView
[10-K] BioNexus Gene Lab Corp Files Annual Report - Stock Titan
BioNexus Gene Lab Corp. Reports Earnings Results for the Full Year Ended December 31, 2025 - marketscreener.com
Analyst Upgrade: Will BioNexus Gene Lab Corp stock recover after earningsPortfolio Profit Report & Precise Entry and Exit Recommendations - baoquankhu1.vn
BioNexus Gene Lab Corp. Auditor Raises 'Going Concern' Doubt - marketscreener.com
Will BioNexus Lab (BGLC) Stock Grow in 2026 | Price at $2.15, Down 4.41%Put Support - newsline.com
Ideas Watch: Does BioNexus Gene Lab Corp stock reflect fundamentalsShare Buyback & Entry Point Strategy Guides - baoquankhu1.vn
BGLC Stock Price, Quote & Chart | BIONEXUS GENE LAB CORP (NASDAQ:BGLC) - ChartMill
How is BioNexus Lab (BGLC) Stock performing in 2026 | Price at $2.30, Up 1.71%Weak Sell Signals - The Legal Advocate
Can BioNexus Lab (BGLC) Stock Go Higher | Price at $2.23, Up 0.98%Bollinger Expansion - newsline.com
BGLC SEC FilingsBionexus Gene La 10-K, 10-Q, 8-K Forms - Stock Titan
[NT 10-K] BioNexus Gene Lab Corp SEC Filing - Stock Titan
12 Industrials Stocks Moving In Tuesday's Pre-Market Session - Benzinga
Volume Recap: Can BioNexus Gene Lab Corp be the next market leader2026 Pullback Review & Stock Portfolio Risk Control - baoquankhu1.vn
Portfolio Update: Is BioNexus Gene Lab Corp in a consolidation phase2026 Sector Review & Daily Growth Stock Tips - baoquankhu1.vn
Will BioNexus Gene Lab Corp stock recover after earningsMarket Activity Recap & Safe Entry Trade Signal Reports - baoquankhu1.vn
Aug Highlights: Does LTRY have declining or rising EPS2026 Intraday Action & Expert Curated Trade Setup Alerts - baoquankhu1.vn
Tech Rally: Will BioNexus Gene Lab Corp outperform its industry peersPortfolio Profit Report & Free Reliable Trade Execution Plans - baoquankhu1.vn
Bionexus Gene Lab Corp (BGLC) 財務データ
収益
当期純利益
現金流量
EPS
3.73%
0.88%
大文字化:
|
ボリューム (24 時間):